In support of our result, analysis of the 327 BC patient samples in GSE20685 confirms that NEDD4 mRNA expression is significantly higher in ER-positive vs. ER-negative BC (Additional file 3: Figure S2; P < 0.001). This evidence concerns the gene NEDD4 and breast cancer.